Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
Abstract Along with the recent spread of multidrug-resistant bacteria, outbreaks of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing bacteria present a serious challenge to clinicians. β-lactam antibiotics are the most frequently used antibacterial agents and ESBLs, and carbapenemase...
Main Authors: | Teiji Sawa, Kunihiko Kooguchi, Kiyoshi Moriyama |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40560-020-0429-6 |
Similar Items
-
Extended-spectrum β-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae
by: Fereshteh Eftekhar, et al.
Published: (2015-11-01) -
Evaluation Frequency of Metallo-β-Lactamases and Carbapenemase Enzymes in Pseudomonas aeruginosa Clinical Isolates
by: Masoumeh Beig, et al.
Published: (2020-06-01) -
Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic <i>Escherichia coli</i> in Cusco, Peru
by: Steev Loyola, et al.
Published: (2021-04-01) -
Metallo β-lactamases: A perspective and implications
by: Rabindra N Misra
Published: (2012-01-01) -
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
by: Annelien Everaert, et al.
Published: (2016-11-01)